跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
布地奈德吸入粉雾剂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Budesonide Inhalation Powder
Approved
化学药品
Budesonide Inhalation Powder
ORION CORPORATION
🇨🇳 National Medical Products Administration
Approval Date
Jul 23, 2024
Approval ID
8btvVi69C15
Company
ORION CORPORATION
Type
化学药品
Approval Details
Approval Id
8btvVi69C15
Approval Number
国药准字HJ20140421
Generic Name
布地奈德吸入粉雾剂
Generic Name En
Budesonide Inhalation Powder
Drug Type
化学药品
Dosage Form
吸入粉雾剂
Strength
每瓶含粉末2.5g,每克粉末含布地奈德25.7mg,每瓶200吸,每吸含布地奈德200μg
Reg Date
2024-07-23
Expired Date
2029-07-22
Company Name
ORION CORPORATION
Production Company Name
ORION CORPORATION
Company Detail Path
/organization/orion-corporation
Production Company Detail Path
/organization/orion-corporation
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 23, 2024
Approval ID
8btvVi69C15
Type
化学药品
Back to NMPA Approvals